"MicroGenDX is Introducing PerioDX, the First Commercially Available Saliva-Based qPCR+NGS Test for Oral Health"

Alzheimer's Disease And The Oral Microbiome​​​

  1. Dominy, Stephen S et al. “Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors.” Science advances vol. 5,1 eaau3333. 23 Jan. 2019, doi:10.1126/sciadv. aau 3333
  2. Haditsch, Ursula et al. ‘Alzheimer’s Disease-Like Neurodegeneration in Porphyromonas Gingivalis Infected Neurons with Persistent Expression of Active Gingipains’. 1 Jan. 2020: 1361 – 1376.
  3. Ingar Olsen, Sim K. Singhrao. (2020) “Porphyromonas gingivalis infection may contribute to systemic and intracerebral amyloid-beta: implications for Alzheimer’s disease onset”. Expert Review of Anti-infective Therapy 18:11, pages 1063-1066.
  4. Matsushita K, Yamada-Furukawa M, Kurosawa M, Shikama Y. “Periodontal Disease and Periodontal Disease-Related Bacteria Involved in the Pathogenesis of Alzheimer’s Disease”. J Inflamm Res. 2020; 13:275-283.
  5. Miklossy, J. “Alzheimer’s disease – a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria”. J Neuroinflammation 8, 90 (2011). https://doi.org/10.1186/1742-2094-8-90
  6. Miklossy, J. (2011). “Emerging roles of pathogens in Alzheimer disease”. Expert Reviews in Molecular Medicine, 13, E30. doi:10.1017/S1462399411002006
  7. Miklossy, J. Alzheimer’s disease – a neurospirochetosis. “Analysis of the evidence following Koch’s and Hill’s criteria”. J Neuroinflammation 8, 90 (2011). 
  8. Miklossy, Judith. “Bacterial Amyloid and DNA Are Important Constituents of Senile Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile Plaques”. 1 Jan. 2016: 1459 – 1473.
  9. Orr, Miranda E et al. “Can oral health and oral-derived biospecimens predict progression of dementia?” Oral diseases vol. 26,2 (2020): 249-258. doi:10.1111/odi.13201
  10. Shoemark DK, Allen SJ. “The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer’s disease”. J Alzheimers Dis. 2015;43(3):725-38. doi: 10.3233/JAD-141170. PMID: 25125469.
  11. Fulop T, Tripathi S, Rodrigues S, et al. Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease. Neuropsychiatr Dis Treat. 2021;17:1311-1339. Published 2021 May 4. doi:10.2147/NDT.S264910 https://pubmed.ncbi.nlm.nih.gov/33976546/